Pancreatic Cells Derived From Pigs therapy(Otsuka Pharmaceutical Factory)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NamePancreatic Cells Derived From Pigs therapy(Otsuka Pharmaceutical Factory)
Drug Alias NameEncapsulated Porcine Islet Cells for Xenotransplantation therapy(Otsuka Pharmaceutical Factory)OPF-310OPF310
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Pancreatic islet cell therapyCell and gene therapy > Cell therapy > Donor > Xenogenic
Mechanisms of ActionPancreatic beta cell replacements
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesImmune System DiseasesHypoglycemia +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOtsuka Pharmaceutical Factory Inc
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Pharmaceutical Factory Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesHypoglycemiaDiabetes Mellitus, Type 1 +[5] 
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A